AptarGroup, Inc.

ATR Healthcare Medical Instruments & Supplies

AptarGroup, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.8 billion, up 5.42% from fiscal 2024.

Revenue
+6.03%
EPS
−73.9%
Free cash flow
−16.9%
Total debt
+14.6%

Quarter to September 2026, against a year earlier

143.84 3.02 −2.06%
Market cap
$9.1B
P/E
34.6×
Fwd P/E
25.9×
Dividend yield
1.00%
F-score
5/9
Altman Z
3.78
Beneish M
−2.48
Dividend safety
92/100

AptarGroup, Inc. 10-K filed Feb 6, 2026

Fiscal year 2025 · Period ended Dec 31, 2025 · Filed · accepted 11:57 AM ET · Document on sec.gov · Filing index

What changed

Item 1, Business, against the 10-K filed Feb 7, 2025: 6 added · 10 removed · 36 modified; 22 with only figures updated

  1. Modified · WHO ARE WE AND WHAT DO WE DO

    Aptar is a global leader in the design and manufacturing of drug and consumer product dosing, dispensing and protection technologies. Aptar serves a number of attractive diversified end markets including pharmaceutical, beautyfragrance, facial skincare, color cosmetics, food, beverage, personal care, and home care. Using market expertise, proprietary design, engineering and, materials science to create innovative solutions for many of the world's leading brands, and manufacturing capabilities, Aptar in turn makes a meaningful difference in the livessupports customers across these end markets by enabling safe, looksfunctional, health and homes of millions of patients differentiated product and consumers around the worldservice delivery. Aptar is headquartered in Crystal Lake, Illinois and has approximately 13,500 dedicated 14,000 employees in approximately 20 different countries. For more information, visit www.aptar.com.